{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T04:13:04Z","timestamp":1793160784742,"version":"4.5.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,18]],"date-time":"2021-10-18T00:00:00Z","timestamp":1634515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,18]],"date-time":"2021-10-18T00:00:00Z","timestamp":1634515200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetol Metab Syndr"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Nonalcoholic fatty liver disease (NAFLD) is one of the most common causes of liver transaminases elevation and a global health concern.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>This study designed to evaluate the effects of turmeric rhizomes (Curcumalonga Linn.) on liver enzymes, Lipid profiles and Malondialdehyde (MDA) in patients with NAFLD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Study design<\/jats:title>\n                <jats:p>Randomized double-blind placebo controlled trial.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>64 cases of NAFLD randomly assigned to receive either turmeric (2 gr\/day) or placebo for 8\u00a0weeks. The changes of liver transaminases, lipid profiles and MDA were measured before and after study period and compared between two groups (IRCT 2015092924262N1).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>At the end of the study, the Turmeric group showed a significant reduction in liver enzymes (AST before 26.81\u2009\u00b1\u200910.54 after 21.19\u2009\u00b1\u20095.67, P\u2009=\u20090.044, ALT before 39.56\u2009\u00b1\u200922.41, after 30.51\u2009\u00b1\u200912.61, P\u2009=\u20090.043 and GGT before33.81\u2009\u00b1\u200917.50, after 25.62\u2009\u00b1\u20099.88, P\u2009=\u20090.046) compared with the placebo group. The serum levels of triglycerides, LDL, HDL and MDA had also a significant decrease among turmeric group as compared to baseline while there was no significant change in placebo group (P\u2009&lt;\u20090.05). The serum cholesterol, VLDL level and sonographic grades of NAFLD had not any significant change in both groups.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>In conclusion this study suggests that daily consumption of turmeric (and its active phenolic ingredients as curcumin) supplementation could be effective in management of NAFLD and decreasing serum level of liver transaminases.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13098-021-00731-7","type":"journal-article","created":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T10:16:32Z","timestamp":1635156992000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["The effect of turmeric on lipid profile, malondialdehyde, liver echogenicity and enzymes among patients with nonalcoholic fatty liver disease: a randomized double blind clinical trial"],"prefix":"10.1186","volume":"13","author":[{"given":"Maryam","family":"jarhahzadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6857-6151","authenticated-orcid":false,"given":"Pezhman","family":"Alavinejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farnaz","family":"Farsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Durdana","family":"Husain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afshin","family":"Rezazadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,18]]},"reference":[{"issue":"3","key":"731_CR1","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1002\/ptr.6542","volume":"34","author":"N Baziar","year":"2020","unstructured":"Baziar N, Parohan M. The effects of curcumin supplementation on body mass index, body weight, and waist circumference in patients with nonalcoholic fatty liver disease: a systematic review and dose\u2013response meta-analysis of randomized controlled trials. Phytother Res. 2020;34(3):464\u201374. https:\/\/doi.org\/10.1002\/ptr.6542.","journal-title":"Phytother Res"},{"key":"731_CR2","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/145754","author":"M Obika","year":"2012","unstructured":"Obika M, Noguchi H. Diagnosis and evaluation of nonalcoholic fatty liver disease. Exp Diabetes Res. 2012. https:\/\/doi.org\/10.1155\/2012\/145754.","journal-title":"Exp Diabetes Res"},{"issue":"29","key":"731_CR3","doi-asserted-by":"publisher","first-page":"3377","DOI":"10.3748\/wjg.v17.i29.3377","volume":"17","author":"S Zelber-Sagi","year":"2011","unstructured":"Zelber-Sagi S, Ratziu V, Oren R. Nutrition and physical activity in NAFLD: an overview of the epidemiological evidence. World J Gastroenterol. 2011;17(29):3377. https:\/\/doi.org\/10.3748\/wjg.v17.i29.3377.","journal-title":"World J Gastroenterol"},{"issue":"5","key":"731_CR4","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/jdi.12093","volume":"4","author":"E Hui","year":"2013","unstructured":"Hui E, Xu A, Bo Yang H, Lam KS. Obesity as the common soil of non-alcoholic fatty liver disease and diabetes: role of adipokines. J diabetes Investig. 2013;4(5):413\u201325. https:\/\/doi.org\/10.1111\/jdi.12093.","journal-title":"J diabetes Investig"},{"issue":"4","key":"731_CR5","doi-asserted-by":"publisher","first-page":"217","DOI":"10.4254\/wjh.v6.i4.217","volume":"6","author":"P Marzuillo","year":"2014","unstructured":"Marzuillo P, del Giudice EM, Santoro N. Pediatric non-alcoholic fatty liver disease: new insights and future directions. World J Hepatol. 2014;6(4):217. https:\/\/doi.org\/10.4254\/wjh.v6.i4.217.","journal-title":"World J Hepatol"},{"issue":"2","key":"731_CR6","doi-asserted-by":"publisher","first-page":"176","DOI":"10.7861\/clinmedicine.11-2-176","volume":"11","author":"CP Day","year":"2011","unstructured":"Day CP. Non-alcoholic fatty liver disease: a massive problem. Clin Med. 2011;11(2):176. https:\/\/doi.org\/10.7861\/clinmedicine.11-2-176.","journal-title":"Clin Med"},{"issue":"1","key":"731_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4292\/wjgpt.v2.i1.1","volume":"2","author":"EA Tsochatzis","year":"2011","unstructured":"Tsochatzis EA, Papatheodoridis GV. Is there any progress in the treatment of non-alcoholic fatty liver disease? World J gastrointest Pharmacol Ther. 2011;2(1):1. https:\/\/doi.org\/10.4292\/wjgpt.v2.i1.1.","journal-title":"World J gastrointest Pharmacol Ther"},{"issue":"4","key":"731_CR8","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1542\/peds.2006-1212","volume":"118","author":"JB Schwimmer","year":"2006","unstructured":"Schwimmer JB, Deutsch R, Kahen T, Lavine JE, Stanley C, Behling C. Prevalence of fatty liver in children and adolescents. Pediatrics. 2006;118(4):1388\u201393. https:\/\/doi.org\/10.1542\/peds.2006-1212.","journal-title":"Pediatrics"},{"issue":"1","key":"731_CR9","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/jgh.12428","volume":"29","author":"Z Li","year":"2014","unstructured":"Li Z, Xue J, Chen P, Chen L, Yan S, Liu L. Prevalence of nonalcoholic fatty liver disease in mainland of China: a meta-analysis of published studies. J Gastroenterol Hepatol. 2014;29(1):42\u201351. https:\/\/doi.org\/10.1111\/jgh.12428.","journal-title":"J Gastroenterol Hepatol"},{"key":"731_CR10","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1097\/01.mcg.0000168638.84840.ff","volume":"40","author":"JM Clark","year":"2006","unstructured":"Clark JM. The epidemiology of nonalcoholic fatty liver disease in adults. J Clin Gastroenterol. 2006;40:S5\u201310. https:\/\/doi.org\/10.1097\/01.mcg.0000168638.84840.ff.","journal-title":"J Clin Gastroenterol"},{"issue":"1","key":"731_CR11","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1053\/j.gastro.2010.09.038","volume":"140","author":"CD Williams","year":"2011","unstructured":"Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, Contreras M, Landt CL, Harrison SA. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology. 2011;140(1):124\u201331. https:\/\/doi.org\/10.1053\/j.gastro.2010.09.038.","journal-title":"Gastroenterology"},{"issue":"14","key":"731_CR12","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1056\/NEJMra0912063","volume":"363","author":"G Targher","year":"2010","unstructured":"Targher G, Day CP, Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med. 2010;363(14):1341\u201350. https:\/\/doi.org\/10.1056\/NEJMra0912063.","journal-title":"N Engl J Med"},{"key":"731_CR13","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/jgh.12212","volume":"28","author":"D Schuppan","year":"2013","unstructured":"Schuppan D, Schattenberg JM. Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches. J Gastroenterol Hepatol. 2013;28:68\u201376. https:\/\/doi.org\/10.1111\/jgh.12212.","journal-title":"J Gastroenterol Hepatol"},{"issue":"26","key":"731_CR14","doi-asserted-by":"publisher","first-page":"8341","DOI":"10.3748\/wjg.v20.i26.8341","volume":"20","author":"M Del Ben","year":"2014","unstructured":"Del Ben M, Polimeni L, Baratta F, Pastori D, Loffredo L, Angelico F. Modern approach to the clinical management of non-alcoholic fatty liver disease. World J Gastroenterol. 2014;20(26):8341. https:\/\/doi.org\/10.3748\/wjg.v20.i26.8341.","journal-title":"World J Gastroenterol"},{"issue":"4","key":"731_CR15","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1080\/07315724.2015.1021057","volume":"35","author":"F Farsi","year":"2016","unstructured":"Farsi F, Mohammadshahi M, Alavinejad P, Rezazadeh A, Zarei M, Engali KA. Functions of coenzyme Q10 supplementation on liver enzymes, markers of systemic inflammation, and adipokines in patients affected by nonalcoholic fatty liver disease: a double-blind, placebo-controlled, randomized clinical trial. J Am Coll Nutr. 2016;35(4):346\u201353. https:\/\/doi.org\/10.1080\/07315724.2015.1021057.","journal-title":"J Am Coll Nutr"},{"issue":"6","key":"731_CR16","first-page":"1108","volume":"3","author":"M Mohammadshahi","year":"2014","unstructured":"Mohammadshahi M, Farsi F, Nejad PA, Hajiani E, Zarei M, Engali KA. The coenzyme Q10 supplementation effects on lipid profile, fasting blood sugar, blood pressure and oxidative stress status among non-alcoholic fatty liver disease patients: a randomized, placebo-controlled, pilot study. J Gastroenterol Hepatol Res. 2014;3(6):1108\u201313.","journal-title":"J Gastroenterol Hepatol Res"},{"issue":"10","key":"731_CR17","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1097\/01.mcg.0000212608.59090.08","volume":"40","author":"K Madan","year":"2006","unstructured":"Madan K, Bhardwaj P, Thareja S, Gupta SD, Saraya A. Oxidant stress and antioxidant status among patients with nonalcoholic fatty liver disease (NAFLD). J Clin Gastroenterol. 2006;40(10):930\u20135. https:\/\/doi.org\/10.1097\/01.mcg.0000212608.59090.08.","journal-title":"J Clin Gastroenterol"},{"issue":"1","key":"731_CR18","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.freeradbiomed.2011.10.003","volume":"52","author":"AP Rolo","year":"2012","unstructured":"Rolo AP, Teodoro JS, Palmeira CM. Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis. Free Radical Biol Med. 2012;52(1):59\u201369. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2011.10.003.","journal-title":"Free Radical Biol Med"},{"issue":"12","key":"731_CR19","first-page":"1858","volume":"4","author":"A Rezazadeh","year":"2015","unstructured":"Rezazadeh A, Mahmoodi M, Mard SA, Karimi Moghaddam E. The effects of dark chocolate consumption on lipid profile, fasting blood sugar, liver enzymes, inflammation, and antioxidant status in patients with non-alcoholic fatty liver disease: a randomized, placebo-controlled, pilot study. J Gastroenterol Hepatol Res. 2015;4(12):1858\u201364.","journal-title":"J Gastroenterol Hepatol Res"},{"key":"731_CR20","doi-asserted-by":"publisher","DOI":"10.18549\/pharmpract.2019.1.1350","author":"CM White","year":"2019","unstructured":"White CM, Lee J-Y. The impact of turmeric or its curcumin extract on nonalcoholic fatty liver disease: a systematic review of clinical trials. Pharm Pract. 2019. https:\/\/doi.org\/10.18549\/pharmpract.2019.1.1350.","journal-title":"Pharm Pract"},{"issue":"3","key":"731_CR21","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1007\/s12072-018-9910-x","volume":"13","author":"Z Wei","year":"2019","unstructured":"Wei Z, Liu N, Tantai X, Xing X, Xiao C, Chen L, Wang J. The effects of curcumin on the metabolic parameters of non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials. Hep Intl. 2019;13(3):302\u201313.","journal-title":"Hep Intl"},{"key":"731_CR22","doi-asserted-by":"publisher","DOI":"10.4103\/0973-8258.44731","author":"JAJ Sunilson","year":"2008","unstructured":"Sunilson JAJ, Jayaraj P, Mohan MS, Kumari AAG, Varatharajan R. Antioxidant and hepatoprotective effect of the roots of Hibiscus esculentus Linn. Int J Green Pharm. 2008. https:\/\/doi.org\/10.4103\/0973-8258.44731.","journal-title":"Int J Green Pharm"},{"issue":"2","key":"731_CR23","first-page":"141","volume":"25","author":"SP Alavinejad","year":"2020","unstructured":"Alavinejad SP, Eshkiki ZS, Pourmousa Z, Zaeemzadeh N, Hashemi SJ, Mard SA. A pilot study of epigallocatechin gallate treatment in patients with non-alcoholic fatty liver. Iran J Gastroenterol Hepatol. 2020;25(2):141.","journal-title":"Iran J Gastroenterol Hepatol"},{"issue":"1","key":"731_CR24","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.imr.2018.07.004","volume":"8","author":"F Mansour-Ghanaei","year":"2019","unstructured":"Mansour-Ghanaei F, Pourmasoumi M, Hadi A, Joukar F. Efficacy of curcumin\/turmeric on liver enzymes in patients with non-alcoholic fatty liver disease: a systematic review of randomized controlled trials. Integr Med Res. 2019;8(1):57\u201361. https:\/\/doi.org\/10.1016\/j.imr.2018.07.004.","journal-title":"Integr Med Res"},{"key":"731_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctim.2019.102283","volume":"48","author":"M Jalali","year":"2020","unstructured":"Jalali M, Mahmoodi M, Mosallanezhad Z, Jalali R, Imanieh MH, Moosavian SP. The effects of curcumin supplementation on liver function, metabolic profile and body composition in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials. Complement Ther Med. 2020;48: 102283. https:\/\/doi.org\/10.1016\/j.ctim.2019.102283.","journal-title":"Complement Ther Med"},{"key":"731_CR26","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.jff.2015.01.005","volume":"18","author":"A Sahebkar","year":"2015","unstructured":"Sahebkar A, Serban M-C, Ursoniu S, Banach M. Effect of curcuminoids on oxidative stress: a systematic review and meta-analysis of randomized controlled trials. J Funct Foods. 2015;18:898\u2013909. https:\/\/doi.org\/10.1016\/j.jff.2015.01.005.","journal-title":"J Funct Foods"},{"issue":"8","key":"731_CR27","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1016\/j.cgh.2015.02.019","volume":"13","author":"A Lang","year":"2015","unstructured":"Lang A, Salomon N, Wu JC, Kopylov U, Lahat A, Har-Noy O, Ching JY, Cheong PK, Avidan B, Gamus D. Curcumin in combination with mesalamine induces remission in patients with mild-to-moderate ulcerative colitis in a randomized controlled trial. Clin Gastroenterol Hepatol. 2015;13(8):1444\u20139. https:\/\/doi.org\/10.1016\/j.cgh.2015.02.019.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"731_CR28","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/283634","author":"E Antiga","year":"2015","unstructured":"Antiga E, Bonciolini V, Volpi W, Del Bianco E, Caproni M. Oral curcumin (Meriva) is effective as an adjuvant treatment and is able to reduce IL-22 serum levels in patients with psoriasis vulgaris. Biomed Res Int. 2015. https:\/\/doi.org\/10.1155\/2015\/283634.","journal-title":"Biomed Res Int"},{"key":"731_CR29","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.phrs.2016.03.026","volume":"107","author":"A Sahebkar","year":"2016","unstructured":"Sahebkar A, Cicero AF, Simental-Mend\u00eda LE, Aggarwal BB, Gupta SC. Curcumin downregulates human tumor necrosis factor-\u03b1 levels: a systematic review and meta-analysis ofrandomized controlled trials. Pharmacol Res. 2016;107:234\u201342. https:\/\/doi.org\/10.1016\/j.phrs.2016.03.026.","journal-title":"Pharmacol Res"},{"issue":"10","key":"731_CR30","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1111\/j.1478-3231.2009.02086.x","volume":"29","author":"Y Rivera-Espinoza","year":"2009","unstructured":"Rivera-Espinoza Y, Muriel P. Pharmacological actions of curcumin in liver diseases or damage. Liver Int. 2009;29(10):1457\u201366. https:\/\/doi.org\/10.1111\/j.1478-3231.2009.02086.x.","journal-title":"Liver Int"},{"issue":"1","key":"731_CR31","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/1472-6882-13-58","volume":"13","author":"S-W Kim","year":"2013","unstructured":"Kim S-W, Ha K-C, Choi E-K, Jung S-Y, Kim M-G, Kwon D-Y, Yang H-J, Kim M-J, Kang H-J, Back H-I. The effectiveness of fermented turmeric powder in subjects with elevated alanine transaminase levels: a randomised controlled study. BMC Complement Altern Med. 2013;13(1):58.","journal-title":"BMC Complement Altern Med"},{"issue":"04","key":"731_CR32","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1055\/s-0043-100019","volume":"67","author":"Y Panahi","year":"2017","unstructured":"Panahi Y, Kianpour P, Mohtashami R, Jafari R, Simental-Mend\u00eda LE, Sahebkar A. Efficacy and safety of phytosomal curcumin in non-alcoholic fatty liver disease: a randomized controlled trial. Drug Res. 2017;67(04):244\u201351. https:\/\/doi.org\/10.1055\/s-0043-100019.","journal-title":"Drug Res"},{"issue":"4","key":"731_CR33","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1080\/07315724.2016.1267597","volume":"36","author":"R Navekar","year":"2017","unstructured":"Navekar R, Rafraf M, Ghaffari A, Asghari-Jafarabadi M, Khoshbaten M. Turmeric supplementation improves serum glucose indices and leptin levels in patients with nonalcoholic fatty liver diseases. J Am Coll Nutr. 2017;36(4):261\u20137. https:\/\/doi.org\/10.1080\/07315724.2016.1267597.","journal-title":"J Am Coll Nutr"},{"issue":"01","key":"731_CR34","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1142\/S0192415X07004679","volume":"35","author":"MF Yam","year":"2007","unstructured":"Yam MF, Basir R, Asmawi MZ, Ismail Z. Antioxidant and hepatoprotective effects of Orthosiphon stamineus Benth. standardized extract. Am J Chin Med. 2007;35(01):115\u201326. https:\/\/doi.org\/10.1142\/S0192415X07004679.","journal-title":"Am J Chin Med"},{"issue":"10","key":"731_CR35","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1155\/2013\/450639","volume":"450639","author":"AN Mavrogiannaki","year":"2013","unstructured":"Mavrogiannaki AN, Migdalis IN. Nonalcoholic fatty liver disease, diabetes mellitus and cardiovascular disease: newer data. Int J Endocrinol. 2013;450639(10):3. https:\/\/doi.org\/10.1155\/2013\/450639.","journal-title":"Int J Endocrinol"},{"issue":"3","key":"731_CR36","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1210\/jc.2004-1024","volume":"90","author":"F Angelico","year":"2005","unstructured":"Angelico F, Del Ben M, Conti R, Francioso S, Feole K, Fiorello S, Cavallo MG, Zalunardo B, Lirussi F, Alessandri C, Violi F. Insulin resistance, the metabolic syndrome, and nonalcoholic fatty liver disease. J Clin Endocrinol Metab. 2005;90(3):1578\u201382. https:\/\/doi.org\/10.1210\/jc.2004-1024.","journal-title":"J Clin Endocrinol Metab"},{"issue":"31","key":"731_CR37","doi-asserted-by":"publisher","first-page":"32345","DOI":"10.1074\/jbc.M313478200","volume":"279","author":"VT Samuel","year":"2004","unstructured":"Samuel VT, Liu ZX, Qu X, Elder BD, Bilz S, Befroy D, Romanelli AJ, Shulman GI. Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease. J Biol Chem. 2004;279(31):32345\u201353. https:\/\/doi.org\/10.1074\/jbc.M313478200.","journal-title":"J Biol Chem"},{"issue":"11","key":"731_CR38","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.3390\/antiox9111092","volume":"9","author":"K Jakubczyk","year":"2020","unstructured":"Jakubczyk K, Dru\u017cga A, Katarzyna J, Skonieczna-\u017bydecka K. Antioxidant potential of curcumin\u2014a meta-analysis of randomized clinical trials. Antioxidants. 2020;9(11):1092. https:\/\/doi.org\/10.3390\/antiox9111092.","journal-title":"Antioxidants"},{"issue":"2","key":"731_CR39","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/ptr.6226","volume":"33","author":"R Tabrizi","year":"2019","unstructured":"Tabrizi R, Vakili S, Akbari M, Mirhosseini N, Lankarani KB, Rahimi M, Mobini M, Jafarnejad S, Vahedpoor Z, Asemi Z. The effects of curcumin-containing supplements on biomarkers of inflammation and oxidative stress: a systematic review and meta-analysis of randomized controlled trials. Phytother Res. 2019;33(2):253\u201362. https:\/\/doi.org\/10.1002\/ptr.6226.","journal-title":"Phytother Res"},{"issue":"7","key":"731_CR40","doi-asserted-by":"publisher","first-page":"367","DOI":"10.3109\/00207454.2012.657380","volume":"122","author":"A Acar","year":"2012","unstructured":"Acar A, Akil E, Alp H, Evliyaoglu O, Kibrisli E, Inal A, Unan F, Tasdemir N. Oxidative damage is ameliorated by curcumin treatment in brain and sciatic nerve of diabetic rats. Int J Neurosci. 2012;122(7):367\u201372. https:\/\/doi.org\/10.3109\/00207454.2012.657380.","journal-title":"Int J Neurosci"},{"issue":"4","key":"731_CR41","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.dld.2010.01.021","volume":"42","author":"P Loria","year":"2010","unstructured":"Loria P, Adinolfi L, Bellentani S, Bugianesi E, Grieco A, Fargion S, Gasbarrini A, Loguercio C, Lonardo A, Marchesini G. Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease: a decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee. Dig Liver Dis. 2010;42(4):272\u201382. https:\/\/doi.org\/10.1016\/j.dld.2010.01.021.","journal-title":"Dig Liver Dis"},{"issue":"4","key":"731_CR42","first-page":"5462","volume":"9","author":"RK Elahi","year":"2012","unstructured":"Elahi RK. Preventive effects of turmeric (Curcuma longa Linn.) powder on hepatic steatosis in the rats fed with high fat diet. Life Sci J. 2012;9(4):5462\u20138.","journal-title":"Life Sci J"},{"issue":"1","key":"731_CR43","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/1472-6882-13-56","volume":"13","author":"SM Salama","year":"2013","unstructured":"Salama SM, Abdulla MA, AlRashdi AS, Ismail S, Alkiyumi SS, Golbabapour S. Hepatoprotective effect of ethanolic extract of Curcuma longa on thioacetamide induced liver cirrhosis in rats. BMC Complement Altern Med. 2013;13(1):56.","journal-title":"BMC Complement Altern Med"},{"issue":"1","key":"731_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF00926033","volume":"137","author":"AC Reddy","year":"1994","unstructured":"Reddy AC, Lokesh BR. Studies on the inhibitory effects of curcumin and eugenol on the formation of reactive oxygen species and the oxidation of ferrous iron. Mol Cell Biochem. 1994;137(1):1\u20138.","journal-title":"Mol Cell Biochem"},{"issue":"12","key":"731_CR45","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1111\/j.2042-7158.1994.tb03258.x","volume":"46","author":"MN Sreejayan","year":"1994","unstructured":"Sreejayan MN. Curcuminoids as potent inhibitors of lipid peroxidation. J Pharm Pharmacol. 1994;46(12):1013\u20136. https:\/\/doi.org\/10.1111\/j.2042-7158.1994.tb03258.x.","journal-title":"J Pharm Pharmacol"},{"issue":"7","key":"731_CR46","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/j.freeradbiomed.2007.12.029","volume":"44","author":"SK Mantena","year":"2008","unstructured":"Mantena SK, King AL, Andringa KK, Eccleston HB, Bailey SM. Mitochondrial dysfunction and oxidative stress in the pathogenesis of alcohol- and obesity-induced fatty liver diseases. Free Radical Biol Med. 2008;44(7):1259\u201372. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2007.12.029.","journal-title":"Free Radical Biol Med"},{"issue":"4","key":"731_CR47","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1053\/jhep.2003.50398","volume":"38","author":"M Perez-Carreras","year":"2003","unstructured":"Perez-Carreras M, Del Hoyo P, Martin MA, Rubio JC, Martin A, Castellano G, Colina F, Arenas J, Solis-Herruzo JA. Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis. Hepatology. 2003;38(4):999\u20131007. https:\/\/doi.org\/10.1053\/jhep.2003.50398.","journal-title":"Hepatology"},{"issue":"13","key":"731_CR48","doi-asserted-by":"publisher","first-page":"3064","DOI":"10.1021\/ja003823x","volume":"123","author":"SV Jovanovic","year":"2001","unstructured":"Jovanovic SV, Boone CW, Steenken S, Trinoga M, Kaskey RB. How curcumin works preferentially with water soluble antioxidants. J Am Chem Soc. 2001;123(13):3064\u20138. https:\/\/doi.org\/10.1021\/ja003823x.","journal-title":"J Am Chem Soc"},{"issue":"4","key":"731_CR49","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/S1357-2725(98)00015-6","volume":"30","author":"JT Piper","year":"1998","unstructured":"Piper JT, Singhal SS, Salameh MS, Torman RT, Awasthi YC, Awasthi S. Mechanisms of anticarcinogenic properties of curcumin: the effect of curcumin on glutathione linked detoxification enzymes in rat liver. Int J Biochem Cell Biol. 1998;30(4):445\u201356. https:\/\/doi.org\/10.1016\/S1357-2725(98)00015-6.","journal-title":"Int J Biochem Cell Biol"},{"issue":"8","key":"731_CR50","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/S0891-5849(00)00294-X","volume":"28","author":"R Motterlini","year":"2000","unstructured":"Motterlini R, Foresti R, Bassi R, Green CJ. Curcumin, an antioxidant and anti-inflammatory agent, induces heme oxygenase-1 and protects endothelial cells against oxidative stress. Free Radical Biol Med. 2000;28(8):1303\u201312. https:\/\/doi.org\/10.1016\/S0891-5849(00)00294-X.","journal-title":"Free Radical Biol Med"},{"issue":"1","key":"731_CR51","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1034\/j.1600-0773.2003.920106.x","volume":"92","author":"M Iqbal","year":"2003","unstructured":"Iqbal M, Sharma SD, Okazaki Y, Fujisawa M, Okada S. Dietary supplementation of curcumin enhances antioxidant and phase II metabolizing enzymes in ddY male mice: possible role in protection against chemical carcinogenesis and toxicity. Pharmacol Toxicol. 2003;92(1):33\u20138. https:\/\/doi.org\/10.1034\/j.1600-0773.2003.920106.x.","journal-title":"Pharmacol Toxicol"},{"issue":"4","key":"731_CR52","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1002\/hep.510300402","volume":"30","author":"AA Nanji","year":"1999","unstructured":"Nanji AA, Jokelainen K, Rahemtulla A, Miao L, Fogt F, Matsumoto H, Tahan SR, Su GL. Activation of nuclear factor kappa B and cytokine imbalance in experimental alcoholic liver disease in the rat. Hepatology. 1999;30(4):934\u201343. https:\/\/doi.org\/10.1002\/hep.510300402.","journal-title":"Hepatology"},{"issue":"15","key":"731_CR53","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1056\/NEJM199704103361506","volume":"336","author":"PJ Barnes","year":"1997","unstructured":"Barnes PJ, Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med. 1997;336(15):1066\u201371.","journal-title":"N Engl J Med"},{"issue":"42","key":"731_CR54","doi-asserted-by":"publisher","first-page":"24995","DOI":"10.1074\/jbc.270.42.24995","volume":"270","author":"S Singh","year":"1995","unstructured":"Singh S, Aggarwal BB. Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane) [corrected]. J Biol Chem. 1995;270(42):24995\u20135000. https:\/\/doi.org\/10.1074\/jbc.270.42.24995.","journal-title":"J Biol Chem"},{"issue":"6","key":"731_CR55","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/S0168-8278(02)00266-0","volume":"37","author":"P Sanz-Cameno","year":"2002","unstructured":"Sanz-Cameno P, Medina J, Garcia-Buey L, Garcia-Sanchez A, Borque MJ, Martin-Vilchez S, Gamallo C, Jones EA, Moreno-Otero R. Enhanced intrahepatic inducible nitric oxide synthase expression and nitrotyrosine accumulation in primary biliary cirrhosis and autoimmune hepatitis. J Hepatol. 2002;37(6):723\u20139. https:\/\/doi.org\/10.1016\/S0168-8278(02)00266-0.","journal-title":"J Hepatol"},{"issue":"4","key":"731_CR56","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1211\/0022357001774048","volume":"52","author":"EJ Park","year":"2000","unstructured":"Park EJ, Jeon CH, Ko G, Kim J, Sohn DH. Protective effect of curcumin in rat liver injury induced by carbon tetrachloride. J Pharm Pharmacol. 2000;52(4):437\u201340. https:\/\/doi.org\/10.1211\/0022357001774048.","journal-title":"J Pharm Pharmacol"},{"issue":"1","key":"731_CR57","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1211\/0022357021771823","volume":"54","author":"HC Kang","year":"2002","unstructured":"Kang HC, Nan JX, Park PH, Kim JY, Lee SH, Woo SW, Zhao YZ, Park EJ, Sohn DH. Curcumin inhibits collagen synthesis and hepatic stellate cell activation in-vivo and in-vitro. J Pharm Pharmacol. 2002;54(1):119\u201326. https:\/\/doi.org\/10.1211\/0022357021771823.","journal-title":"J Pharm Pharmacol"},{"issue":"9","key":"731_CR58","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1002\/ptr.5659","volume":"30","author":"S Rahmani","year":"2016","unstructured":"Rahmani S, Asgary S, Askari G, Keshvari M, Hatamipour M, Feizi A, Sahebkar A. Treatment of non-alcoholic fatty liver disease with curcumin: a randomized placebo-controlled trial. Phytother Res. 2016;30(9):1540\u20138. https:\/\/doi.org\/10.1002\/ptr.5659.","journal-title":"Phytother Res"},{"issue":"1","key":"731_CR59","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.diabet.2012.11.002","volume":"39","author":"K Gariani","year":"2013","unstructured":"Gariani K, Philippe J, Jornayvaz FR. Non-alcoholic fatty liver disease and insulin resistance: from bench to bedside. Diabetes Metab. 2013;39(1):16\u201326. https:\/\/doi.org\/10.1016\/j.diabet.2012.11.002.","journal-title":"Diabetes Metab"},{"key":"731_CR60","first-page":"887","volume":"5","author":"NA Ismail","year":"2014","unstructured":"Ismail NA, Ragab S, Abd El Baky A, Hamed M, Ibrahim A. Effect of oral curcumin administration on insulin resistance, serum resistin and fetuin-A in obese children: randomized placebo-controlled study. Res J Pharm Biol Chem Sci. 2014;5:887\u201396.","journal-title":"Res J Pharm Biol Chem Sci"},{"issue":"2","key":"731_CR61","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.jnutbio.2013.09.013","volume":"25","author":"S Chuengsamarn","year":"2014","unstructured":"Chuengsamarn S, Rattanamongkolgul S, Phonrat B, Tungtrongchitr R, Jirawatnotai S. Reduction of atherogenic risk in patients with type 2 diabetes by curcuminoid extract: a randomized controlled trial. J Nutr Biochem. 2014;25(2):144\u201350. https:\/\/doi.org\/10.1016\/j.jnutbio.2013.09.013.","journal-title":"J Nutr Biochem"},{"issue":"1","key":"731_CR62","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1111\/hdi.12204","volume":"19","author":"M Pakfetrat","year":"2015","unstructured":"Pakfetrat M, Akmali M, Malekmakan L, Dabaghimanesh M, Khorsand M. Role of turmeric in oxidative modulation in end-stage renal disease patients. Hemodial Int. 2015;19(1):124\u201331. https:\/\/doi.org\/10.1111\/hdi.12204.","journal-title":"Hemodial Int"},{"issue":"5","key":"731_CR63","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/S0022-2275(20)42003-6","volume":"37","author":"K Schoonjans","year":"1996","unstructured":"Schoonjans K, Staels B, Auwerx J. Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression. J Lipid Res. 1996;37(5):907\u201325. https:\/\/doi.org\/10.1016\/S0022-2275(20)42003-6.","journal-title":"J Lipid Res"},{"issue":"12","key":"731_CR64","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1002\/mnfr.201100440","volume":"55","author":"SK Shin","year":"2011","unstructured":"Shin SK, Ha TY, McGregor RA, Choi MS. Long-term curcumin administration protects against atherosclerosis via hepatic regulation of lipoprotein cholesterol metabolism. Mol Nutr Food Res. 2011;55(12):1829\u201340. https:\/\/doi.org\/10.1002\/mnfr.201100440.","journal-title":"Mol Nutr Food Res"},{"issue":"265","key":"731_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118856","volume":"15","author":"M Zarei","year":"2021","unstructured":"Zarei M, Acharya P, Talahalli RR. Ginger and turmeric lipid-solubles attenuate heated oil-induced hepatic inflammation via the downregulation of NF-kB in rats. Life Sci. 2021;15(265): 118856.","journal-title":"Life Sci"},{"issue":"10","key":"731_CR66","doi-asserted-by":"publisher","first-page":"504","DOI":"10.3390\/antiox8100504","volume":"8","author":"PM Boarescu","year":"2019","unstructured":"Boarescu PM, Boarescu I, Boc\u0219an IC, Gheban D, Bulboac\u0103 AE, Nicula C, Pop RM, R\u00e2jnoveanu RM, Bolboac\u0103 SD. Antioxidant and anti-inflammatory effects of curcumin nanoparticles on drug-induced acute myocardial infarction in diabetic rats. Antioxidants. 2019;8(10):504.","journal-title":"Antioxidants"}],"container-title":["Diabetology &amp; Metabolic Syndrome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-021-00731-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13098-021-00731-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-021-00731-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T10:18:33Z","timestamp":1635157113000},"score":1,"resource":{"primary":{"URL":"https:\/\/dmsjournal.biomedcentral.com\/articles\/10.1186\/s13098-021-00731-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,18]]},"references-count":66,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["731"],"URL":"https:\/\/doi.org\/10.1186\/s13098-021-00731-7","relation":{},"ISSN":["1758-5996"],"issn-type":[{"value":"1758-5996","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,18]]},"assertion":[{"value":"5 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study approved by the Ethical Committee of Ahvaz Jundishapur University of Medical Sciences (IR.Ajums.rec.1394.104).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"112"}}